Virchow's triad revisited: Blood constituents

被引:101
作者
Chung, I [1 ]
Lip, GYH [1 ]
机构
[1] Univ Birmingham, City Hosp, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B18 7QH, W Midlands, England
关键词
Virchow's triad; thrombosis; platelets; P-selectin; fibrinogen; fibrin; D-dimer; fibrinolysis;
D O I
10.1159/000083844
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An update of Virchow's triad for thrombogenesis can be considered by reference to abnormalities in the endothelium/endocardium ('abnormal vessel wall'), abnormalities of haemorhelogy and turbulence at bifurcations, atheroma at vessel wall ('abnormal blood flow') and abnormalities in platelet as well as the coagulation and fibrinolytic pathways ('abnormal blood constituents'). The constituents of the blood are many and varied, but soluble coagulation factors (such as fibrinogen and tissue factor) and cells (such as platelets) are clearly important. Clearly, 'a continuum exists between health, 'statistically' increased haemostatic abnormalities in prothrombotic or hypercoagulable states and 'overtly' increased clotting in acute thrombosis. Thus, the patients with the highest levels of the markers appear to be the highest risk of disease progression, and if so, a panel of 'high risk' blood constituent indices (platelet and coagulation markers) may potentially give a composite score of risk, and may be a useful tool in predicting subjects at highest risk. Further longitudinal studies are clearly required. There is no doubt that Virchow would be impressed on how his classical triad has expanded to encompass the wide range of pathophysiological processes leading to thrombogenesis. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:449 / 454
页数:6
相关论文
共 49 条
[1]   TISSUE-TYPE PLASMINOGEN-ACTIVATOR ANTIGEN AND PLASMINOGEN-ACTIVATOR INHIBITOR IN DIABETES-MELLITUS [J].
AUWERX, J ;
BOUILLON, R ;
COLLEN, D ;
GEBOERS, J .
ARTERIOSCLEROSIS, 1988, 8 (01) :68-72
[2]  
BANERJEE AK, 1992, THROMB HAEMOSTASIS, V68, P261
[3]   Hemostatic function and progressing ischemic stroke - D-dimer predicts early clinical progression [J].
Barber, M ;
Langhorne, P ;
Rumley, A ;
Lowe, GDO ;
Stott, DJ .
STROKE, 2004, 35 (06) :1421-1425
[4]   Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function [J].
Bavenholm, P ;
de Faire, U ;
Landou, C ;
Efendic, S ;
Nilsson, J ;
Wiman, B ;
Hamsten, A .
EUROPEAN HEART JOURNAL, 1998, 19 (03) :402-410
[5]   EVALUATION OF BETA-THROMBOGLOBULIN LEVELS IN CANCER-PATIENTS - EFFECTS OF ANTI-TUMOR CHEMOTHERAPY [J].
BIDET, JM ;
FERRIERE, JP ;
BESSE, G ;
CHOLLET, P ;
GAILLARD, G ;
PLAGNE, R .
THROMBOSIS RESEARCH, 1980, 19 (03) :429-433
[6]   Hypothesis: Is soluble P-selectin a new marker of platelet activation? [J].
Blann, AD ;
Lip, GYH .
ATHEROSCLEROSIS, 1997, 128 (02) :135-138
[7]   BETA-THROMBOGLOBULIN, PLATELET PRODUCTION TIME AND PLATELET-FUNCTION IN VASCULAR-DISEASE [J].
CELLA, G ;
ZAHAVI, J ;
DEHAAS, HA ;
KAKKAR, VV .
BRITISH JOURNAL OF HAEMATOLOGY, 1979, 43 (01) :127-136
[8]   Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong [J].
Cheng, SWK ;
Ting, ACW ;
Lau, H ;
Wong, J .
WORLD JOURNAL OF SURGERY, 1999, 23 (02) :202-206
[9]   Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation [J].
Conway, DSG ;
Pearce, LA ;
Chin, BSP ;
Hart, RG ;
Lip, GYH .
CIRCULATION, 2003, 107 (25) :3141-3145
[10]   Plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation - Relationship to stroke risk factors [J].
Conway, DSG ;
Pearce, LA ;
Chin, BSP ;
Hart, RG ;
Lip, GYH .
CIRCULATION, 2002, 106 (15) :1962-1967